Axsome Therapeutics, Inc. (AXSM)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-04) · 99.1 · 99.2 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-23) · 99.1 | 8-K (2026-01-12) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-03) · 99.1 · 99.2 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-04) · 99.1 · 99.2 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-05) · 99.1 · 99.2 | ||
| 10-K | FY-2024 | 8-K (2025-02-18) · 99.1 · 99.2 | 8-K (2025-01-13) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-12) · 99.1 · 99.2 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-05) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-06) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-20) · 99.1 | 8-K (2024-01-04) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-06) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-07) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Stockholders' Equity | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accounts Receivable, Net | ||
| Accrued Expenses and Other Current Liabilities | ||
| Acquisitions | ||
| Business Combination | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Managaement, Strategy, and Governance Disclosure | — |
|
| Fair Value of Financial Instruments | ||
| Goodwill | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Intangible Assets | ||
| Inventory | ||
| License Agreements | ||
| Loan and Security Agreement | ||
| Nature of Business and Basis of Presentation | ||
| Net Loss Per Common Share | ||
| Pay Vs Performance Disclosure | ||
| Related Party Transactions | ||
| Related-party Transactions | — |
|
| Revenues | ||
| Royalty Agreements | ||
| Segment Information | ||
| Stockholders' Equity | ||
| Subsequent Events | — |
|
| Summary of Significant Accounting Policies | ||
| Warrants | ||